European Union - English - EMA (European Medicines Agency)

chanelle pharmaceuticals manufacturing limited - meloxicam - oxicams, anti-inflammatory and anti-rheumatic products, non-steroids - dogs; horses; cats; cattle; pigs - dogsalleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in dogs. to reduce post-operative pain and inflammation following orthopaedic and soft tissue surgery.catsreduction of post-operative pain after ovariohysterectomy and minor soft tissue surgery.alleviation of mild to moderate post-operative pain and inflammation following surgical procedures in cats, e.g. orthopaedic and soft tissue surgery.alleviation of pain and inflammation in acute and chronic musculo-skeletal disorders in cats.cattlefor use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs. for use in diarrhoea in combination with oral re-hydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle. for adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy.pigsfor use in non-infectious locomotor disorders to reduce the symptoms of lameness and inflammation. for adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy. for the relief of post operative pain associated with minor soft tissue such as castration.horsesalleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders in horses..for the relief of pain associated with equine colic.

Australia - English - Department of Health (Therapeutic Goods Administration)

gedeon richter australia pty ltd - cariprazine hydrochloride, quantity: 6.54 mg (equivalent: cariprazine, qty 6 mg) - capsule, hard - excipient ingredients: pregelatinised maize starch; magnesium stearate; titanium dioxide; brilliant blue fcf; allura red ac; gelatin; propylene glycol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; ethanol absolute; iron oxide black; potassium hydroxide - reagila? is indicated for the treatment of schizophrenia in adult patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

gedeon richter australia pty ltd - cariprazine hydrochloride, quantity: 4.905 mg (equivalent: cariprazine, qty 4.5 mg) - capsule, hard - excipient ingredients: pregelatinised maize starch; magnesium stearate; titanium dioxide; brilliant blue fcf; iron oxide yellow; allura red ac; gelatin; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; simethicone; ethanol; shellac; sulfuric acid - reagila? is indicated for the treatment of schizophrenia in adult patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

gedeon richter australia pty ltd - cariprazine hydrochloride, quantity: 3.27 mg (equivalent: cariprazine, qty 3 mg) - capsule, hard - excipient ingredients: pregelatinised maize starch; magnesium stearate; titanium dioxide; brilliant blue fcf; iron oxide yellow; allura red ac; gelatin; propylene glycol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; ethanol absolute; iron oxide black; potassium hydroxide - reagila? is indicated for the treatment of schizophrenia in adult patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

gedeon richter australia pty ltd - cariprazine hydrochloride, quantity: 1.635 mg (equivalent: cariprazine, qty 1.5 mg) - capsule, hard - excipient ingredients: magnesium stearate; pregelatinised maize starch; titanium dioxide; gelatin; propylene glycol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; ethanol absolute; iron oxide black; potassium hydroxide - reagila? is indicated for the treatment of schizophrenia in adult patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

gedeon richter australia pty ltd - levonorgestrel, quantity: 1.5 mg - tablet, uncoated - excipient ingredients: potato starch; maize starch; purified talc; lactose monohydrate; colloidal anhydrous silica; magnesium stearate - emergency contraception within 72 hours of unprotected intercourse.

Australia - English - Department of Health (Therapeutic Goods Administration)

gedeon richter australia pty ltd - teriparatide, quantity: 250 microgram/ml - injection, solution - excipient ingredients: metacresol; water for injections; sodium hydroxide; hydrochloric acid; glacial acetic acid; mannitol; sodium acetate trihydrate - terrosa is indicated for the treatment of osteoporosis in postmenopausal women and the treatment of primary osteoporosis in men when other agents are considered unsuitable and when there is a high risk of fractures.,terrosa is indicated for the treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at high risk for fracture.

Australia - English - Department of Health (Therapeutic Goods Administration)

gedeon richter australia pty ltd - follitropin alfa, quantity: 300 iu - injection, solution - excipient ingredients: poloxamer; sucrose; dibasic sodium phosphate dihydrate; monobasic sodium phosphate dihydrate; methionine; phosphoric acid; thymidine; trypsin - in adult women:,- afolia is indicated for the treatment of anovulatory infertility in women who have been unresponsive to clomiphene citrate or where clomiphene citrate is contraindicated,- controlled ovarian hyperstimulation in women undergoing assisted reproductive technologies,- afolia in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level <1.2 iu/l.,in adult men:,- afolia is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.